Combining targeted therapy with immunotherapy (interferon-α): Rational, efficacy in gastrointestinal stromal tumor model and implications in other malignancies

Imatinib revolutionized gastrointestinal stromal tumor (GIST) treatment but median-progression-free-survival of unresectable/metastatic disease is < 2 y. B-RAF(V600)-mutated-melanoma responds to vemurafenib dramatically but median-progression-free-survival is < 9 mo. Combining imatinib with im...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Chen, Lei L., Gouw, Launce, Sabripour, Mahyar, Hwu, Wen-Jen, Benjamin, Robert S.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Landes Bioscience 2012
Aiheet:
Author's View
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3429591/
https://ncbi.nlm.nih.gov/pubmed/22934279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.19729
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia